157327-96-3

157327-96-3 structure

Name: 3’-dC(Bz)-2’-phosphor amidite
Chemical Name: 3'-dc cep
CAS Number: 157327-96-3
Molecular Formula: C₄₆H₅₂N₅O₈P
Molecular Weight: 833.91
Catalog: Signaling Pathways Cell Cycle/DNA Damage Nucleoside Antimetabolite/Analog
Create Date: 2017-09-24 23:40:23
Modify Date: 2026-08-24 18:26:48
3’-dC(Bz)-2’-phosphor amidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

Name	3'-dc cep
Synonyms	3'-dC-CE Phosphoramidite 3’-dC(Bz)-2’-phosphoramidite N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-deoxycytidine 2'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] N4-Benzoyl-5’-O-(4,4-dimethoxytrityl)-3’-deoxycytidine-2’-CED-phosphoramidite 5'-Dimethoxytrityl-N-benzoyl-3'-deoxyCytidine,2'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite Midostaurin Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-deoxy-, 2'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) N6-Benzoyl-3'-deoxy-5'-O-DMT-cytidine 2'-CE phosphoramidite 4-N-benzoyl-3'-deoxy-5'-O-(4,4'-dimethoxytrityl)cytidine 2-cyanoethyl N,N-diisopropylphosphoramidite 4'-N-benzoylstaurosporine 3'-dC(Bz)-2'-phosphor amidite Cgp 41 251 N6-Benzoyl-5'-O-DMT-3'-deoxycytidine 2'-CE phosphoramidite 4'-N-benzoyl staurosprine 3'-dC (2R,3R,5S)-2-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite Benzoylstaurosporine 3'-DC C

Description	3’-dC(Bz)-2’-phosphor amidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog
References	[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.

124482-92-4

86234-45-9

~65%

157327-96-3

Literature: Jung Kyeong Eun; Switzer Journal of the American Chemical Society, 1994 , vol. 116, # 14 p. 6059 - 6061

102691-36-1

86234-45-9

~77%

157327-96-3

Literature: Kumar, Anil; Dass, Debasis; Atreyi; Rao; Katti Nucleosides, Nucleotides and Nucleic Acids, 2001 , vol. 20, # 10-11 p. 1783 - 1796

40615-36-9

157327-96-3

Literature: Kumar, Anil; Dass, Debasis; Atreyi; Rao; Katti Nucleosides, Nucleotides and Nucleic Acids, 2001 , vol. 20, # 10-11 p. 1783 - 1796

98-88-4

157327-96-3

Literature: Kumar, Anil; Dass, Debasis; Atreyi; Rao; Katti Nucleosides, Nucleotides and Nucleic Acids, 2001 , vol. 20, # 10-11 p. 1783 - 1796

161110-00-5

157327-96-3

Literature: Kumar, Anil; Dass, Debasis; Atreyi; Rao; Katti Nucleosides, Nucleotides and Nucleic Acids, 2001 , vol. 20, # 10-11 p. 1783 - 1796

7057-33-2

157327-96-3

Literature: Kumar, Anil; Dass, Debasis; Atreyi; Rao; Katti Nucleosides, Nucleotides and Nucleic Acids, 2001 , vol. 20, # 10-11 p. 1783 - 1796